Related by context. All words. (Click for frequent words.) 69 refractory CLL 66 refractory AML 65 relapsed refractory multiple myeloma 64 refractory multiple myeloma 62 refractory Hodgkin lymphoma 62 relapsed multiple myeloma 62 relapsed MM 62 refractory APL 62 symptomatic BPH 62 refractory acute myeloid 61 MAGE A3 ASCI 61 adalimumab Humira 61 Pemetrexed 61 phase IIb trial 61 refractory PTCL 61 Cariprazine 61 pegylated interferon alpha 61 Cloretazine 61 refractory myeloma 61 bendamustine 61 refractory systemic ALCL 61 leukemia CLL 61 Revlimid lenalidomide 61 heavily pretreated 61 temsirolimus 61 PREZISTA r 60 leukemia AML 60 refractory indolent non 60 VELCADE melphalan 60 refractory follicular lymphoma 60 refractory CTCL 60 YONDELIS 60 Gemzar ® 60 refractory cutaneous T 60 azacitidine 60 refractory ALCL 60 dose escalation phase 60 cell lymphoma CTCL 59 SCIg 59 refractory chronic lymphocytic 59 Velcade bortezomib 59 lumiliximab 59 visilizumab 59 relapsing remitting MS RRMS 59 invasive aspergillosis 59 Degarelix 59 Tarceva TM 59 phase IIb clinical 59 Teriflunomide 59 invasive candidiasis 59 ISTODAX 59 metastatic renal cell carcinoma 59 tocilizumab 59 Eltrombopag 59 metastatic RCC 59 dacetuzumab 59 metastatic malignant 59 forodesine 58 relapsed 58 Nexavar sorafenib 58 Sprycel dasatinib 58 Myelodysplastic Syndrome MDS 58 Tipranavir 58 peginterferon alfa 2a 58 leukemia ALL 58 riociguat 58 Alemtuzumab 58 recurrent glioblastoma multiforme 58 complete cytogenetic response 58 protease inhibitor PI 58 RRMS patients 58 Aflibercept 58 Phase IIIb clinical 58 anagrelide 58 thalidomide Thalomid 58 remission induction 58 NATRECOR R 58 doripenem 58 vandetanib 58 Rilonacept 58 Hepatocellular Carcinoma HCC 58 aripiprazole Abilify 58 Jevtana 58 Raptiva ® 58 dasatinib Sprycel ® 58 sargramostim 58 KRN# 58 lapatinib Tykerb 58 INTELENCE 58 Lu AA# 58 chronic HCV infection 58 sorafenib Nexavar 58 oral ridaforolimus 58 APTIVUS r 58 refractory NSCLC 58 peginterferon 58 ZOLINZA 58 herpes zoster shingles 58 castration resistant prostate cancer 58 Gleevec imatinib 58 eosinophilic asthma 58 depression TRD 57 phase Ib clinical 57 alkylating agent 57 Seliciclib 57 recurrent GBM 57 Golimumab 57 PegIFN RBV 57 Fibrillex TM 57 Plicera 57 Intravenous CP 57 intravenous bisphosphonates 57 leukemia APL 57 lymphoma CTCL 57 axitinib 57 erlotinib Tarceva ® 57 relapsed ovarian cancer 57 Gleevec resistant 57 phase III isavuconazole 57 docetaxel Taxotere R 57 psoriatic arthritis PsA 57 RSD# oral 57 canakinumab 57 refractory Hodgkin 57 anthracycline taxane 57 allogeneic stem cell 57 dacarbazine 57 sunitinib malate 57 platinum refractory 57 mitoxantrone plus 57 Omacetaxine 57 dopamine partial agonist 57 EndoTAG TM -1 57 AQ4N 57 CML CP 57 relapsed leukemia 57 evaluating tivozanib 57 herpetic keratitis 57 pharmacokinetic interactions 57 esophageal candidiasis 57 TORISEL 57 HBV infections 57 Sudhir Agrawal D.Phil 57 Ophena TM 57 cutaneous T cell 57 Iressa gefitinib 57 dasatinib 57 grade cervical intraepithelial 57 PSMA ADC 57 basiliximab 57 PD LID 57 FOLOTYN ® 57 Arzerra ofatumumab 57 tigecycline 57 relapsing remitting multiple sclerosis 57 docetaxel chemotherapy 57 Dacogen decitabine 57 CIMZIA ™ 57 chemotherapy docetaxel 57 efalizumab 57 BARACLUDE ® 57 Allovectin 7 ® 57 HER2 positive metastatic breast 57 mapatumumab 57 regorafenib 57 idiopathic pulmonary fibrosis IPF 57 SHPT 57 INSPIRE Trial Phase III 57 colorectal liver metastases 57 SUPPRELIN R LA 57 CIMZIA TM 57 octreotide LAR 57 antibody MAb 57 APTIVUS 57 CYT# potent vascular disrupting 57 Phase Ib clinical 57 recombinant interferon 57 iclaprim 57 FASLODEX 57 MERLIN TIMI 57 doxorubicin HCl liposome injection 57 refractory lymphoma 57 ExTRACT TIMI 57 interferon therapy 57 Femara letrozole 57 baminercept 57 standard chemotherapy regimen 57 metastatic GIST 57 oxaliplatin Eloxatin 57 RhuDex ® 57 atypical Hemolytic Uremic Syndrome 56 imatinib therapy 56 REVLIMID lenalidomide 56 metastatic castration resistant 56 abacavir lamivudine 56 Onrigin 56 nilotinib 56 TYGACIL 56 Certolizumab pegol 56 dasatinib Sprycel 56 virus HCV protease inhibitor 56 Cloretazine ® 56 Azacitidine 56 posaconazole 56 gastrointestinal stromal tumors GIST 56 methotrexate therapy 56 phase IIb study 56 goserelin 56 Dasatinib 56 eribulin mesylate 56 trabectedin 56 efavirenz EFV 56 active comparator 56 sevelamer 56 chlorambucil 56 evaluable subjects 56 antiretroviral naive 56 tinidazole 56 oral vancomycin 56 elotuzumab 56 infliximab 56 lenalidomide Revlimid R 56 PROSTVAC ® 56 refractory metastatic colorectal cancer 56 prostate cancer HRPC 56 relapsed CLL 56 Bortezomib 56 lanthanum carbonate 56 midstage clinical 56 Xanafide 56 systemic anaplastic large 56 superficial bladder cancer 56 Elvitegravir 56 huC# DM4 56 non metastatic osteosarcoma 56 PegIntron 56 CBLC# 56 Tocilizumab 56 TYSABRI natalizumab 56 BEXXAR 56 olaparib 56 ACTEMRA TM 56 Advagraf 56 tenofovir emtricitabine 56 indolent NHL 56 Epratuzumab 56 castrate resistant prostate cancer 56 mCRC patients 56 candesartan cilexetil 56 treatment naive genotype 56 zanolimumab 56 ziconotide 56 quetiapine fumarate 56 phase Ib 56 MGd 56 investigational monoclonal antibody 56 AIM HIGH 56 Dose escalation 56 SSRI antidepressant 56 achieved sustained virologic 56 NeuroStar TMS Therapy 56 Arranon 56 Cetrorelix pamoate 56 BENLYSTA belimumab 56 chronic ITP patients 56 romiplostim 56 INCB# [001] 56 Noxafil 56 triphendiol 56 Deferiprone 56 etanercept Enbrel 56 boosted protease inhibitor 56 PEGINTRON TM 56 PEG SN# 56 Combination therapy 56 relapsed GBM 56 Herceptin trastuzumab 56 IV acetaminophen 56 APTIVUS ritonavir 56 schizophrenia CIAS 56 maximal doses 56 FOSRENOL ® 56 interferon ribavirin 56 atherothrombotic events 56 gemcitabine cisplatin 56 candidemia 56 refractory SCLC 56 bevacizumab Avastin ® 56 Bendamustine 56 insulin glulisine 56 pomalidomide 56 Pazopanib 56 mycophenolate mofetil 56 thymalfasin 56 Phase Ib study 56 galiximab 56 bevacizumab Avastin 56 chronic GVHD 56 detectable HCV RNA 56 lupus nephritis 56 KNS # 56 relapsing multiple sclerosis 56 FOLFOX4 56 diabetic neuropathic pain 56 Pegasys ® 56 Vidaza azacitidine 56 Serdolect ® 56 teriflunomide 56 long acting bronchodilator 56 OncoVEX GM CSF 56 erlotinib Tarceva 56 refractory acute promyelocytic 56 follicular lymphoma FL 56 interferon gamma 1b 56 Navelbine ® 56 Myelodysplastic Syndrome 56 pyrazinamide 56 selective modulator 56 Proellex TM 56 dacarbazine DTIC 56 ponatinib 56 metastatic kidney 56 divalproex sodium 56 FOLFIRI chemotherapy 56 abatacept 56 Mipomersen 56 Traficet EN 56 Tavocept 56 Valcyte 55 Glucophage XR 55 KRAS mutations occur 55 relapsing MS 55 alvespimycin 55 HuMax CD4 55 dalteparin 55 lomitapide 55 AA Amyloidosis 55 tipranavir 55 sorafenib tablets 55 Egrifta 55 idarubicin 55 oral mTOR inhibitor 55 Amrubicin 55 malignant pleural mesothelioma 55 intravitreal insert 55 sorafenib Nexavar ® 55 EMPHASIS HF trial 55 evaluating Xcytrin 55 #I TM# 55 nucleoside analogues 55 Irinotecan 55 investigational pan BCR 55 Pegloticase 55 refractory gout 55 mGluR5 NAM 55 Daclizumab 55 Phenoptin 55 AVASTIN 55 risperidone Risperdal 55 heavily pretreated patients 55 reboxetine 55 MabCampath 55 HSCT 55 EGFR TKI 55 LEUKINE 55 iniparib 55 Doxil ® 55 RSR# 55 vinflunine 55 StemEx 55 venlafaxine XR 55 Intervention Effectiveness 55 IMA# 55 CDP# 55 cilengitide 55 Actimmune ® 55 DFMO 55 acute gout flares 55 OvaRex ® MAb 55 LUX Lung 55 MULTAQ 55 dirucotide 55 mRCC 55 secondary hyperparathyroidism 55 VaD 55 nitazoxanide 55 tipranavir ritonavir 55 AEGR 55 paclitaxel Taxol R 55 pegylated interferon alfa 55 resistant ovarian cancer 55 SPRYCEL ® 55 Cutaneous T 55 PROCRIT 55 adult chronic ITP 55 HCV SPRINT 55 ritonavir boosted lopinavir 55 Interferon beta 1b 55 flutamide 55 CHOP chemotherapy 55 anti angiogenic therapy 55 nab paclitaxel 55 TNF antagonist 55 haloperidol Haldol 55 Riluzole 55 Torisel 55 EOquin TM phase 55 chronic ITP 55 E1 INT TM 55 ritonavir boosted 55 EOquin TM 55 mesylate 55 Diabetic Macular Edema 55 imatinib Gleevec ® 55 biliary tract cancer 55 NATRECOR ® 55 Adalimumab 55 Sapacitabine 55 docetaxel Taxotere ® 55 metaglidasen 55 biologic therapy 55 CTAP# Capsules 55 Sanofi Aventis Taxotere 55 HCV infected 55 Mitoxantrone 55 HuMax EGFr 55 ocrelizumab 55 rufinamide 55 DAPT 55 decitabine 55 chronic HBV 55 Lenalidomide 55 Tamibarotene 55 imatinib mesylate 55 PROCRIT ® 55 mTOR inhibitor 55 oral rivaroxaban 55 ER CHOP 55 ABSSSI 55 telaprevir dosed 55 chemopreventive agent 55 Hormone Refractory Prostate Cancer 55 atypical antipsychotic medication 55 pegylated interferons 55 recurrent ovarian cancer 55 citalopram hydrobromide 55 peginterferon alfa 55 Aptivus ® 55 suppressive therapy 55 Tasigna nilotinib 55 Annamycin 55 aripiprazole 55 recurrent VTE 55 taxane refractory 55 TNF antagonist therapy 55 GW# [003] 55 radiation sensitizer 55 elacytarabine 55 severe hypercholesterolemia 55 aprepitant 55 neoadjuvant therapy 55 Meets Primary Endpoint 55 voriconazole 55 Tanespimycin 55 ximelagatran 55 HCV infection 55 cinacalcet 55 Sutent sunitinib 55 SEROQUEL XR 55 β blockers 55 HER2 overexpression 55 CANCIDAS 55 BAY #-# 55 desvenlafaxine 55 anticancer compound 55 systemic ALCL 55 STRIDE PD 55 cytarabine daunorubicin 55 alefacept 55 estramustine 55 metastatic hormone refractory 55 IV metastatic melanoma 55 ELOXATIN 55 sorafenib Nexavar R 55 PKC# 55 JAK inhibitor 55 oxymorphone ER 55 recurrent genital herpes 55 NOXAFIL 55 receptor tyrosine kinase inhibitor 55 noninfectious uveitis 55 subcutaneously administered 55 targeted radiotherapeutic 55 AA amyloidosis 55 investigational protease inhibitor 55 myelodysplastic syndrome MDS 55 virological failure 55 TAXOTERE ® 55 hyperuricemia 55 trastuzumab Herceptin ® 55 Mylotarg 55 recurrent glioblastoma 55 ancrod 55 T2DM 55 Voreloxin 55 advanced NSCLC 55 Amplimexon 55 PROVENGE sipuleucel T 55 AMN# [001] 55 oral Hycamtin 55 risperidone olanzapine 55 cyclophosphamide methotrexate 54 vidofludimus 54 Lenocta 54 abiraterone 54 GLP1 agonist 54 chronic angina 54 eltrombopag 54 VFEND 54 peg interferon 54 metformin hydrochloride 54 EXJADE 54 Moxifloxacin 54 Zemplar Capsules 54 olmesartan 54 atypical antipsychotic 54 Crizotinib 54 cetuximab Erbitux 54 acute mania 54 primary hypercholesterolemia 54 Afatinib 54 miconazole Lauriad R 54 Ceplene/IL-2 54 randomized multicenter trial 54 phase IIa 54 dose colchicine 54 HBeAg negative 54 biologic DMARD 54 dose cytarabine 54 angiotensin II receptor blocker 54 sunitinib 54 hematological malignancy 54 Oxaliplatin 54 pertuzumab 54 ARIXTRA 54 Azilect ® 54 dose escalation clinical 54 BCR ABL inhibitors 54 q8h 54 Welchol 54 rasagiline tablets 54 imatinib resistant 54 antiplatelet agent 54 cisplatin chemotherapy 54 velafermin 54 PRADAXA 54 Pertuzumab 54 systemic antifungal 54 hyperphenylalaninemia HPA due 54 ZYVOX 54 non nucleoside HCV 54 Omnitarg 54 COREG 54 intravenously administered 54 strontium ranelate 54 fluorouracil 54 ara C 54 daunorubicin 54 Ceflatonin 54 BioNumerik 54 Hypoactive Sexual Desire Disorder 54 oxypurinol 54 Hydroxyurea 54 vildagliptin 54 Entecavir 54 double blinded randomized 54 erlotinib 54 ENESTnd 54 Virulizin ® 54 HuLuc# 54 stage IIIB 54 stage IIIB IV 54 FACTIVE tablets 54 deferiprone 54 SNT-MC#/idebenone 54 Nuvion 54 Peginterferon 54 abatacept Orencia 54 phase IIb 54 ixabepilone 54 tipifarnib 54 PXD# 54 Bevacizumab 54 inhalation powder 54 oral methylnaltrexone 54 Pagoclone 54 cutaneous T 54 Linagliptin 54 COPAXONE R 54 GnRH agonist 54 anthracyclines taxanes 54 interferon alfa 2b 54 ONGLYZA ™ 54 IFN alfa 54 IMiDs 54 uric acid lowering 54 eribulin 54 metastatic colorectal 54 relapsed myeloma 54 anti TNF alpha 54 treatment naïve genotype 54 ACZ# 54 ribavirin RBV 54 cysteamine bitartrate 54 migalastat HCl 54 Lamotrigine 54 placebo dexamethasone 54 acetylcholinesterase inhibitor 54 null responder HCV 54 docetaxel Taxotere 54 SCCHN 54 amoxicillin clavulanate 54 pseudobulbar affect PBA 54 bortezomib Velcade 54 CCR5 receptor antagonist 54 ifosfamide 54 capecitabine Xeloda 54 REBETOL combination therapy 54 clinically evaluable 54 cabazitaxel 54 xanthine oxidase inhibitor 54 tenofovir Viread 54 relapsed refractory 54 Naive Patients 54 viral kinetics 54 clodronate 54 interferon beta 1b 54 ONGLYZA saxagliptin 54 antitumor effect 54 rilonacept 54 Hypotension 54 fulvestrant 54 severe renal impairment 54 intravesical infusion therapy 54 Atrasentan 54 potentially hepatotoxic 54 HCV NS5B polymerase 54 vinorelbine 54 LUMINATE 54 Maribavir 54 ipratropium bromide 54 Bezielle 54 FSAD 54 TEMODAL 54 Pirfenidone 54 Peginterferon alfa 2b 54 zidovudine lamivudine 54 insulin sensitizing 54 antiepileptic drug 54 phase IIIb 54 SNT MC# 54 Abilify aripiprazole 54 amphotericin B 54 TLK# 54 abacavir Ziagen 54 generation purine nucleoside 54 primary immunodeficiency PI 54 Silodosin 54 elvucitabine 54 Treanda bendamustine 54 decompensated liver disease 54 TACE 54 lesinurad 54 BCIRG 54 palifosfamide 54 opiate dependence 54 5-fluorouracil/leucovorin 54 reduce serum phosphate 54 oral antiviral 54 Fludara 54 Telcyta 54 refractory chronic myeloid 54 BCG refractory 54 HeFH 54 IGF 1R inhibitor 54 immune thrombocytopenic purpura ITP 54 refractory peripheral T 54 Lofexidine 54 zidovudine AZT 54 Zenvia ™ 54 Zerenex 54 oral antifungal 54 MADIT II 54 prostate cancer CRPC 54 miconazole Lauriad ® 54 cytoreduction 54 XEOMIN 54 CALGB # [002] 54 oral antidiabetic 54 INC# 54 blood phenylalanine Phe 54 Cinquil 54 proteasome inhibitor 54 adalimumab 54 severe gastroparesis 54 nonsmall cell lung cancer 54 untreated AML 54 CD# monoclonal antibody 54 ADAGIO study 54 IMiDs R 54 Atripla combines 54 entecavir 54 trastuzumab DM1 54 huN# DM1 54 reversing heparin 54 hepatitis C HCV 54 maleate 54 pegylated liposomal doxorubicin 54 anakinra 54 levofloxacin 54 elevated LDL cholesterol 54 omalizumab 54 icatibant 54 glufosfamide 54 Neovascular Age Related Macular 54 AEG# 54 Tarceva erlotinib 54 Abiraterone Acetate 54 ceftriaxone 54 ZACTIMA 54 smoking cessation therapies 54 Civacir 54 muraglitazar 54 myeloproliferative disorders 54 acute leukemias 54 LEXIVA r 54 CR# vcMMAE 54 afatinib 54 #D#C# 54 Pixantrone 54 TMC# C# 54 fluorouracil leucovorin 54 beta 1a 54 tacrolimus ointment 54 MYLOTARG 54 tesmilifene 54 recurrent malignant glioma 54 Aripiprazole 54 Pafuramidine 54 anti TNF 54 anticancer therapy 54 Valcyte tablets 54 HBV infection 54 randomized multicenter Phase III 54 cetuximab Erbitux R 54 ribavirin Copegus 54 Apaziquone 54 echinocandin 54 REVIVE Diabetes 54 Pulmonary Arterial Hypertension 54 functional dyspepsia 54 Apixaban 54 Methylnaltrexone 54 overt nephropathy 54 TELCYTA 54 allogeneic HSCT 54 relapsed SCLC 54 Paxil paroxetine 54 dexanabinol 54 acute HAE attacks 54 Immune reconstitution syndrome 54 agalsidase alfa 54 recurrent NSCLC 54 Yervoy 54 Roche Xeloda 54 Epivir 54 generalized anxiety disorder GAD 54 measurable tumor regressions 54 colesevelam HCl 54 imatinib resistance 54 fluvastatin 54 multiple myeloma MM 54 metastatic renal cell 54 Arcalyst 54 acute GvHD 54 Relapsing Remitting Multiple Sclerosis 54 imatinib Gleevec 54 capecitabine Xeloda R 54 BEACOPP 54 CoFactor 53 dapsone 53 ARIXTRA R 53 monotherapy 53 metastatic CRC 53 fosamprenavir 53 Dacogen injection 53 PNP inhibitor 53 HQK 53 interferon beta therapy 53 Pixuvri 53 RESIST studies 53 Kivexa 53 gastrointestinal stromal tumors 53 gefitinib Iressa 53 MCyR 53 nicardipine 53 alvimopan 53 atherogenic dyslipidemia 53 Paliperidone ER 53 galantamine 53 Certican 53 COMBIVIR 53 potent triglyceride lowering 53 invasive fungal infection 53 HBeAg positive 53 pancreatic insufficiency 53 relapsed MCL 53 rimonabant #mg 53 alemtuzumab treated 53 LY# [003] 53 MELD scores 53 Axitinib 53 prucalopride 53 blinded randomized placebo controlled 53 caspofungin 53 abiraterone acetate 53 INVEGA ® 53 tanespimycin 53 Cimzia TM 53 darunavir ritonavir 53 allogeneic bone marrow 53 romidepsin 53 Genasense ® 53 gemcitabine Gemzar 53 meropenem 53 thiazolidinedione 53 rALLy clinical trial 53 USL# 53 oral JAK#/JAK# inhibitor 53 atrasentan 53 Phase #b/#a clinical 53 Phase #b/#a 53 TNF alpha inhibitor 53 hypercalcemia 53 aflibercept VEGF Trap 53 brand ciclesonide HFA 53 vorinostat 53 CLARITY study 53 pimozide 53 paroxetine Paxil 53 hepatitis C genotype 53 previously untreated follicular 53 liposomal formulation 53 AVONEX ® 53 relapsed indolent NHL 53 Friedreich Ataxia FRDA 53 stavudine 53 Etravirine 53 SIMCOR 53 MyVax R 53 Celebrex celecoxib 53 Bicifadine 53 via intradermal injections 53 ganetespib 53 chemo radiotherapy 53 Fondaparinux 53 thorough QT 53 R# #mg BID 53 refractory ovarian cancer 53 weekly subcutaneous injections 53 PPAR gamma agonist 53 forodesine hydrochloride 53 Telmisartan 53 Etanercept 53 Tasimelteon 53 UDCA 53 CIMZIA TM certolizumab pegol 53 Ozarelix 53 nephrotoxic drugs 53 salmeterol fluticasone 53 PHX# 53 chemoradiation 53 Cimzia R 53 diabetic gastroparesis 53 serum phosphate 53 Azathioprine 53 metformin sulfonylurea 53 R sorafenib tablets 53 BRIM3 53 topotecan 53 DPP4 53 subcutaneous PRO 53 bisphosphonate therapy 53 de novo kidney transplant 53 RoACTEMRA 53 Phase Ib 53 Chronic Myeloid Leukemia 53 deletion 5q 53 FluCAM 53 nucleoside reverse transcriptase inhibitor 53 eritoran 53 FOLFIRI 53 metastatic bladder 53 plus dexamethasone 53 oral diclofenac 53 postoperative chemotherapy 53 PSN# [002] 53 interferon alfa 53 cytogenetic responses 53 GSK# [002] 53 reslizumab 53 Complicated Skin 53 Aliskiren 53 mertansine 53 formoterol fumarate 53 Platinol ® 53 pazopanib 53 CATIE AD 53 Toxicities 53 budesonide foam 53 non nucleoside inhibitor 53 epoetin beta 53 Betaferon ® 53 Advaxis Phase 53 bosutinib 53 ALS #-# 53 Aviptadil 53 darinaparsin 53 Procoralan 53 bacillus Calmette Guerin BCG 53 gastrointestinal stromal tumor GIST 53 glucocorticoid induced osteoporosis 53 glatiramer acetate Copaxone 53 Triapine 53 fostamatinib 53 Tesmilifene 53 elective PCI 53 vinca alkaloid 53 follicular NHL 53 Mycamine 53 EchoCRT 53 achieved CCyR 53 Corlux 53 ADVANCE PD 53 REMICADE ® 53 sertraline Zoloft 53 tecarfarin 53 beclomethasone dipropionate 53 free survival PFS 53 brivaracetam 53 HCQ 53 pegylated interferon alfa 2a 53 oropharyngeal candidiasis 53 HBeAg 53 KRAS mutant tumors 53 Phase Ib II 53 adefovir 53 ULORIC 53 tuberculin skin testing 53 Major Depressive Disorder 53 mg kg dose 53 Phase 2a trial 53 Vandetanib 53 Pegasys peginterferon alfa 2a 53 Zarnestra 53 Valdoxan 53 sitaxsentan 53 CytoFabTM 53 uridine triacetate 53 alfa 2a 53 Dementia Related Psychosis 53 Dapagliflozin 53 EOquin 53 Nilotinib 53 hepatic encephalopathy 53 refractory indolent NHL 53 GnRH agonists 53 Cethromycin 53 Hsp# Inhibitor 53 Reverset 53 nilotinib Tasigna ® 53 Desmopressin 53 TMS Therapy 53 pancreatic neuroendocrine tumors 53 Dabigatran etexilate 53 Raptiva r 53 Gleevec imatinib mesylate 53 partial onset seizures 53 bezafibrate 53 prospective randomized multicenter 53 taxane chemotherapy 53 Mg Usa 53 adjuvant colon cancer 53 neuroleptic 53 Neoadjuvant 53 Tyrima 53 CYPHER Stent 53 thetreatment 53 SCENESSE ®